Fitzgerald, Maya

"Pharmaceutical Pricing"

---

Major: Biological Sciences

Junior, College of Health and Sciences

---

Abstract

Drug price regulations in the United States remains a heavily debated issue as medication prices prove unaffordable. Foreign countries have demonstrated successful implementation of price ceilings and reference pricing to lower costs; however, government price control methods could hurt biopharmaceutical companies through reductions in overall revenue and investor hesitancy. Additionally, consumers would face production delays on existing drugs along with reduced access to breakthrough drugs. Another method of price reduction that could lower prices without hurting the industry could include reducing the number of patents in order to reduce company expenditures, resulting in a lesser need for high drug prices.

Class: Honors 201

Professor: Rose Spalding

Department of Political Science